SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-17-000933
Filing Date
2017-05-12
Accepted
2017-05-12 16:47:44
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B3 nemus_424b3.htm 424B3 337150
2 AMENDMENT TO CERTIFICATE OF DESIGNATION nemus_ex31.htm EX-3.1 2752
3 FORM OF AMENDMENT TO WARRANT nemus_ex32.htm EX-3.2 12988
4 SECURITIES PURCHASE AGREEMENT nemus_ex101.htm EX-10.1 132005
5 PRESS RELEASE nemus_ex991.htm EX-99.1 10607
6 nemus_424b3img1.jpg GRAPHIC 10052
7 nemus_ex331img1.jpg GRAPHIC 8093
8 nemus_ex31img1.jpg GRAPHIC 63576
9 nemus_ex31img2.jpg GRAPHIC 112828
10 nemus_ex31img3.jpg GRAPHIC 126359
11 nemus_ex31img4.jpg GRAPHIC 130142
  Complete submission text file 0001640334-17-000933.txt   1118503
Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-216664 | Film No.: 17839388
SIC: 2834 Pharmaceutical Preparations